Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CCZ1B - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CEP41 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CYB5R4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GNS - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GRAP2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
AGAP2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SDC2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RABL2A - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors
NDUFS6 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RNF8 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MYO15A - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MRPL13 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TFG - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GDPD5 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MAN2C1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RWDD1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
FKBP3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
IPO7 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
HDDC2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
VDR - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on